-
XW0V Bones
-
XW0V0 Open
-
XW0V00 Brexanolone
-
XW0V00 Spesolimab Monoclonal Antibody
-
XW0V01 Daratumumab and Hyaluronidase-fihj
-
XW0V01 Eladocagene exuparvovec
-
XW0V02 Bromelain-enriched Proteolytic Enzyme
-
XW0V02 Nerinitide
-
XW0V03 Durvalumab Antineoplastic
-
XW0V03 Maribavir Anti-infective
-
XW0V04 Teclistamab Antineoplastic
-
XW0V05 Mosunetuzumab Antineoplastic
-
XW0V05 Narsoplimab Monoclonal Antibody
-
XW0V06 Afamitresgene Autoleucel Immunotherapy
-
XW0V06 Lefamulin Anti-infective
-
XW0V06 Terlipressin
-
XW0V07 Coagulation Factor Xa, Inactivated
-
XW0V07 Tabelecleucel Immunotherapy
-
XW0V07 Trilaciclib
-
XW0V08 Lurbinectedin
-
XW0V08 Mineral-based Topical Hemostatic Agent
-
XW0V08 Treosulfan
-
XW0V08 Uridine Triacetate
-
XW0V09 Ceftolozane/Tazobactam Anti-infective
-
XW0V09 Inebilizumab-cdon
-
XW0V09 Satralizumab-mwge
-
XW0V0A Cefiderocol Anti-infective
-
XW0V0A Ciltacabtagene Autoleucel
-
XW0V0B Amivantamab Monoclonal Antibody
-
XW0V0B Cytarabine and Daunorubicin Liposome Antineoplastic
-
XW0V0B Omadacycline Anti-infective
-
XW0V0C Eculizumab
-
XW0V0C Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
-
XW0V0D Atezolizumab Antineoplastic
-
XW0V0D Engineered Allogeneic Thymus Tissue
-
XW0V0E Etesevimab Monoclonal Antibody
-
XW0V0E Remdesivir Anti-infective
-
XW0V0F Bamlanivimab Monoclonal Antibody
-
XW0V0F Other New Technology Therapeutic Substance
-
XW0V0G Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
-
XW0V0G Plazomicin Anti-infective
-
XW0V0G REGN-COV2 Monoclonal Antibody
-
XW0V0G Sarilumab
-
XW0V0H Axicabtagene Ciloleucel Immunotherapy
-
XW0V0H Other New Technology Monoclonal Antibody
-
XW0V0H Synthetic Human Angiotensin II
-
XW0V0H Tocilizumab
-
XW0V0J Apalutamide Antineoplastic
-
XW0V0J Tisagenlecleucel Immunotherapy
-
XW0V0K Fosfomycin Anti-infective
-
XW0V0K Idecabtagene Vicleucel Immunotherapy
-
XW0V0K Leronlimab Monoclonal Antibody
-
XW0V0L CD24Fc Immunomodulator
-
XW0V0L Erdafitinib Antineoplastic
-
XW0V0L Lifileucel Immunotherapy
-
XW0V0M Baricitinib
-
XW0V0M Brexucabtagene Autoleucel Immunotherapy
-
XW0V0M Esketamine Hydrochloride
-
XW0V0N Lisocabtagene Maraleucel Immunotherapy
-
XW0V0N Meropenem-vaborbactam Anti-infective
-
XW0V0P Antibiotic-eluting Bone Void Filler
-
XW0V0P7Introduction of Antibiotic-eluting Bone Void Filler into Bones, Open Approach, New Technology Group 7
-
-
XW0V0Q Tagraxofusp-erzs Antineoplastic
-
XW0V0R Fostamatinib
-
XW0V0R Venetoclax Antineoplastic
-
XW0V0S COVID-19 Vaccine Dose 1
-
XW0V0S Iobenguane I-131 Antineoplastic
-
XW0V0T COVID-19 Vaccine Dose 2
-
XW0V0T Ruxolitinib
-
XW0V0U COVID-19 Vaccine
-
XW0V0U Imipenem-cilastatin-relebactam Anti-infective
-
XW0V0V COVID-19 Vaccine Dose 3
-
XW0V0V Gilteritinib Antineoplastic
-
XW0V0W Caplacizumab
-
XW0V0W COVID-19 Vaccine Booster
-
XW0V0X Broad Consortium Microbiota-based Live Biotherapeutic Suspension
-
XW0V0X Tixagevimab and Cilgavimab Monoclonal Antibody
-
XW0V0Y Other New Technology Monoclonal Antibody
-
-
XW0V3 Percutaneous
-
XW0V30 Brexanolone
-
XW0V30 Spesolimab Monoclonal Antibody
-
XW0V31 Daratumumab and Hyaluronidase-fihj
-
XW0V31 Eladocagene exuparvovec
-
XW0V32 Bromelain-enriched Proteolytic Enzyme
-
XW0V32 Nerinitide
-
XW0V33 Durvalumab Antineoplastic
-
XW0V33 Maribavir Anti-infective
-
XW0V34 Teclistamab Antineoplastic
-
XW0V35 Mosunetuzumab Antineoplastic
-
XW0V35 Narsoplimab Monoclonal Antibody
-
XW0V36 Afamitresgene Autoleucel Immunotherapy
-
XW0V36 Lefamulin Anti-infective
-
XW0V36 Terlipressin
-
XW0V37 Coagulation Factor Xa, Inactivated
-
XW0V37 Tabelecleucel Immunotherapy
-
XW0V37 Trilaciclib
-
XW0V38 Lurbinectedin
-
XW0V38 Mineral-based Topical Hemostatic Agent
-
XW0V38 Treosulfan
-
XW0V38 Uridine Triacetate
-
XW0V39 Ceftolozane/Tazobactam Anti-infective
-
XW0V39 Inebilizumab-cdon
-
XW0V39 Satralizumab-mwge
-
XW0V3A Cefiderocol Anti-infective
-
XW0V3A Ciltacabtagene Autoleucel
-
XW0V3B Amivantamab Monoclonal Antibody
-
XW0V3B Cytarabine and Daunorubicin Liposome Antineoplastic
-
XW0V3B Omadacycline Anti-infective
-
XW0V3C Eculizumab
-
XW0V3C Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
-
XW0V3D Atezolizumab Antineoplastic
-
XW0V3D Engineered Allogeneic Thymus Tissue
-
XW0V3E Etesevimab Monoclonal Antibody
-
XW0V3E Remdesivir Anti-infective
-
XW0V3F Bamlanivimab Monoclonal Antibody
-
XW0V3F Other New Technology Therapeutic Substance
-
XW0V3G Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
-
XW0V3G Plazomicin Anti-infective
-
XW0V3G REGN-COV2 Monoclonal Antibody
-
XW0V3G Sarilumab
-
XW0V3H Axicabtagene Ciloleucel Immunotherapy
-
XW0V3H Other New Technology Monoclonal Antibody
-
XW0V3H Synthetic Human Angiotensin II
-
XW0V3H Tocilizumab
-
XW0V3J Apalutamide Antineoplastic
-
XW0V3J Tisagenlecleucel Immunotherapy
-
XW0V3K Fosfomycin Anti-infective
-
XW0V3K Idecabtagene Vicleucel Immunotherapy
-
XW0V3K Leronlimab Monoclonal Antibody
-
XW0V3L CD24Fc Immunomodulator
-
XW0V3L Erdafitinib Antineoplastic
-
XW0V3L Lifileucel Immunotherapy
-
XW0V3M Baricitinib
-
XW0V3M Brexucabtagene Autoleucel Immunotherapy
-
XW0V3M Esketamine Hydrochloride
-
XW0V3N Lisocabtagene Maraleucel Immunotherapy
-
XW0V3N Meropenem-vaborbactam Anti-infective
-
XW0V3P Antibiotic-eluting Bone Void Filler
-
XW0V3Q Tagraxofusp-erzs Antineoplastic
-
XW0V3R Fostamatinib
-
XW0V3R Venetoclax Antineoplastic
-
XW0V3S COVID-19 Vaccine Dose 1
-
XW0V3S Iobenguane I-131 Antineoplastic
-
XW0V3T COVID-19 Vaccine Dose 2
-
XW0V3T Ruxolitinib
-
XW0V3U COVID-19 Vaccine
-
XW0V3U Imipenem-cilastatin-relebactam Anti-infective
-
XW0V3V COVID-19 Vaccine Dose 3
-
XW0V3V Gilteritinib Antineoplastic
-
XW0V3W Caplacizumab
-
XW0V3W COVID-19 Vaccine Booster
-
XW0V3X Broad Consortium Microbiota-based Live Biotherapeutic Suspension
-
XW0V3X Tixagevimab and Cilgavimab Monoclonal Antibody
-
XW0V3Y Other New Technology Monoclonal Antibody
-
-
XW0V7 Via Natural or Artificial Opening
-
XW0V70 Brexanolone
-
XW0V70 Spesolimab Monoclonal Antibody
-
XW0V71 Daratumumab and Hyaluronidase-fihj
-
XW0V71 Eladocagene exuparvovec
-
XW0V72 Bromelain-enriched Proteolytic Enzyme
-
XW0V72 Nerinitide
-
XW0V73 Durvalumab Antineoplastic
-
XW0V73 Maribavir Anti-infective
-
XW0V74 Teclistamab Antineoplastic
-
XW0V75 Mosunetuzumab Antineoplastic
-
XW0V75 Narsoplimab Monoclonal Antibody
-
XW0V76 Afamitresgene Autoleucel Immunotherapy
-
XW0V76 Lefamulin Anti-infective
-
XW0V76 Terlipressin
-
XW0V77 Coagulation Factor Xa, Inactivated
-
XW0V77 Tabelecleucel Immunotherapy
-
XW0V77 Trilaciclib
-
XW0V78 Lurbinectedin
-
XW0V78 Mineral-based Topical Hemostatic Agent
-
XW0V78 Treosulfan
-
XW0V78 Uridine Triacetate
-
XW0V79 Ceftolozane/Tazobactam Anti-infective
-
XW0V79 Inebilizumab-cdon
-
XW0V79 Satralizumab-mwge
-
XW0V7A Cefiderocol Anti-infective
-
XW0V7A Ciltacabtagene Autoleucel
-
XW0V7B Amivantamab Monoclonal Antibody
-
XW0V7B Cytarabine and Daunorubicin Liposome Antineoplastic
-
XW0V7B Omadacycline Anti-infective
-
XW0V7C Eculizumab
-
XW0V7C Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
-
XW0V7D Atezolizumab Antineoplastic
-
XW0V7D Engineered Allogeneic Thymus Tissue
-
XW0V7E Etesevimab Monoclonal Antibody
-
XW0V7E Remdesivir Anti-infective
-
XW0V7F Bamlanivimab Monoclonal Antibody
-
XW0V7F Other New Technology Therapeutic Substance
-
XW0V7G Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
-
XW0V7G Plazomicin Anti-infective
-
XW0V7G REGN-COV2 Monoclonal Antibody
-
XW0V7G Sarilumab
-
XW0V7H Axicabtagene Ciloleucel Immunotherapy
-
XW0V7H Other New Technology Monoclonal Antibody
-
XW0V7H Synthetic Human Angiotensin II
-
XW0V7H Tocilizumab
-
XW0V7J Apalutamide Antineoplastic
-
XW0V7J Tisagenlecleucel Immunotherapy
-
XW0V7K Fosfomycin Anti-infective
-
XW0V7K Idecabtagene Vicleucel Immunotherapy
-
XW0V7K Leronlimab Monoclonal Antibody
-
XW0V7L CD24Fc Immunomodulator
-
XW0V7L Erdafitinib Antineoplastic
-
XW0V7L Lifileucel Immunotherapy
-
XW0V7M Baricitinib
-
XW0V7M Brexucabtagene Autoleucel Immunotherapy
-
XW0V7M Esketamine Hydrochloride
-
XW0V7N Lisocabtagene Maraleucel Immunotherapy
-
XW0V7N Meropenem-vaborbactam Anti-infective
-
XW0V7P Antibiotic-eluting Bone Void Filler
-
XW0V7Q Tagraxofusp-erzs Antineoplastic
-
XW0V7R Fostamatinib
-
XW0V7R Venetoclax Antineoplastic
-
XW0V7S COVID-19 Vaccine Dose 1
-
XW0V7S Iobenguane I-131 Antineoplastic
-
XW0V7T COVID-19 Vaccine Dose 2
-
XW0V7T Ruxolitinib
-
XW0V7U COVID-19 Vaccine
-
XW0V7U Imipenem-cilastatin-relebactam Anti-infective
-
XW0V7V COVID-19 Vaccine Dose 3
-
XW0V7V Gilteritinib Antineoplastic
-
XW0V7W Caplacizumab
-
XW0V7W COVID-19 Vaccine Booster
-
XW0V7X Broad Consortium Microbiota-based Live Biotherapeutic Suspension
-
XW0V7X Tixagevimab and Cilgavimab Monoclonal Antibody
-
XW0V7Y Other New Technology Monoclonal Antibody
-
-
XW0V8 Via Natural or Artificial Opening Endoscopic
-
XW0V80 Brexanolone
-
XW0V80 Spesolimab Monoclonal Antibody
-
XW0V81 Daratumumab and Hyaluronidase-fihj
-
XW0V81 Eladocagene exuparvovec
-
XW0V82 Bromelain-enriched Proteolytic Enzyme
-
XW0V82 Nerinitide
-
XW0V83 Durvalumab Antineoplastic
-
XW0V83 Maribavir Anti-infective
-
XW0V84 Teclistamab Antineoplastic
-
XW0V85 Mosunetuzumab Antineoplastic
-
XW0V85 Narsoplimab Monoclonal Antibody
-
XW0V86 Afamitresgene Autoleucel Immunotherapy
-
XW0V86 Lefamulin Anti-infective
-
XW0V86 Terlipressin
-
XW0V87 Coagulation Factor Xa, Inactivated
-
XW0V87 Tabelecleucel Immunotherapy
-
XW0V87 Trilaciclib
-
XW0V88 Lurbinectedin
-
XW0V88 Mineral-based Topical Hemostatic Agent
-
XW0V88 Treosulfan
-
XW0V88 Uridine Triacetate
-
XW0V89 Ceftolozane/Tazobactam Anti-infective
-
XW0V89 Inebilizumab-cdon
-
XW0V89 Satralizumab-mwge
-
XW0V8A Cefiderocol Anti-infective
-
XW0V8A Ciltacabtagene Autoleucel
-
XW0V8B Amivantamab Monoclonal Antibody
-
XW0V8B Cytarabine and Daunorubicin Liposome Antineoplastic
-
XW0V8B Omadacycline Anti-infective
-
XW0V8C Eculizumab
-
XW0V8C Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
-
XW0V8D Atezolizumab Antineoplastic
-
XW0V8D Engineered Allogeneic Thymus Tissue
-
XW0V8E Etesevimab Monoclonal Antibody
-
XW0V8E Remdesivir Anti-infective
-
XW0V8F Bamlanivimab Monoclonal Antibody
-
XW0V8F Other New Technology Therapeutic Substance
-
XW0V8G Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
-
XW0V8G Plazomicin Anti-infective
-
XW0V8G REGN-COV2 Monoclonal Antibody
-
XW0V8G Sarilumab
-
XW0V8H Axicabtagene Ciloleucel Immunotherapy
-
XW0V8H Other New Technology Monoclonal Antibody
-
XW0V8H Synthetic Human Angiotensin II
-
XW0V8H Tocilizumab
-
XW0V8J Apalutamide Antineoplastic
-
XW0V8J Tisagenlecleucel Immunotherapy
-
XW0V8K Fosfomycin Anti-infective
-
XW0V8K Idecabtagene Vicleucel Immunotherapy
-
XW0V8K Leronlimab Monoclonal Antibody
-
XW0V8L CD24Fc Immunomodulator
-
XW0V8L Erdafitinib Antineoplastic
-
XW0V8L Lifileucel Immunotherapy
-
XW0V8M Baricitinib
-
XW0V8M Brexucabtagene Autoleucel Immunotherapy
-
XW0V8M Esketamine Hydrochloride
-
XW0V8N Lisocabtagene Maraleucel Immunotherapy
-
XW0V8N Meropenem-vaborbactam Anti-infective
-
XW0V8P Antibiotic-eluting Bone Void Filler
-
XW0V8Q Tagraxofusp-erzs Antineoplastic
-
XW0V8R Fostamatinib
-
XW0V8R Venetoclax Antineoplastic
-
XW0V8S COVID-19 Vaccine Dose 1
-
XW0V8S Iobenguane I-131 Antineoplastic
-
XW0V8T COVID-19 Vaccine Dose 2
-
XW0V8T Ruxolitinib
-
XW0V8U COVID-19 Vaccine
-
XW0V8U Imipenem-cilastatin-relebactam Anti-infective
-
XW0V8V COVID-19 Vaccine Dose 3
-
XW0V8V Gilteritinib Antineoplastic
-
XW0V8W Caplacizumab
-
XW0V8W COVID-19 Vaccine Booster
-
XW0V8X Broad Consortium Microbiota-based Live Biotherapeutic Suspension
-
XW0V8X Tixagevimab and Cilgavimab Monoclonal Antibody
-
XW0V8Y Other New Technology Monoclonal Antibody
-
-
XW0VX External
-
XW0VX0 Brexanolone
-
XW0VX0 Spesolimab Monoclonal Antibody
-
XW0VX1 Daratumumab and Hyaluronidase-fihj
-
XW0VX1 Eladocagene exuparvovec
-
XW0VX2 Bromelain-enriched Proteolytic Enzyme
-
XW0VX2 Nerinitide
-
XW0VX3 Durvalumab Antineoplastic
-
XW0VX3 Maribavir Anti-infective
-
XW0VX4 Teclistamab Antineoplastic
-
XW0VX5 Mosunetuzumab Antineoplastic
-
XW0VX5 Narsoplimab Monoclonal Antibody
-
XW0VX6 Afamitresgene Autoleucel Immunotherapy
-
XW0VX6 Lefamulin Anti-infective
-
XW0VX6 Terlipressin
-
XW0VX7 Coagulation Factor Xa, Inactivated
-
XW0VX7 Tabelecleucel Immunotherapy
-
XW0VX7 Trilaciclib
-
XW0VX8 Lurbinectedin
-
XW0VX8 Mineral-based Topical Hemostatic Agent
-
XW0VX8 Treosulfan
-
XW0VX8 Uridine Triacetate
-
XW0VX9 Ceftolozane/Tazobactam Anti-infective
-
XW0VX9 Inebilizumab-cdon
-
XW0VX9 Satralizumab-mwge
-
XW0VXA Cefiderocol Anti-infective
-
XW0VXA Ciltacabtagene Autoleucel
-
XW0VXB Amivantamab Monoclonal Antibody
-
XW0VXB Cytarabine and Daunorubicin Liposome Antineoplastic
-
XW0VXB Omadacycline Anti-infective
-
XW0VXC Eculizumab
-
XW0VXC Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
-
XW0VXD Atezolizumab Antineoplastic
-
XW0VXD Engineered Allogeneic Thymus Tissue
-
XW0VXE Etesevimab Monoclonal Antibody
-
XW0VXE Remdesivir Anti-infective
-
XW0VXF Bamlanivimab Monoclonal Antibody
-
XW0VXF Other New Technology Therapeutic Substance
-
XW0VXG Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
-
XW0VXG Plazomicin Anti-infective
-
XW0VXG REGN-COV2 Monoclonal Antibody
-
XW0VXG Sarilumab
-
XW0VXH Axicabtagene Ciloleucel Immunotherapy
-
XW0VXH Other New Technology Monoclonal Antibody
-
XW0VXH Synthetic Human Angiotensin II
-
XW0VXH Tocilizumab
-
XW0VXJ Apalutamide Antineoplastic
-
XW0VXJ Tisagenlecleucel Immunotherapy
-
XW0VXK Fosfomycin Anti-infective
-
XW0VXK Idecabtagene Vicleucel Immunotherapy
-
XW0VXK Leronlimab Monoclonal Antibody
-
XW0VXL CD24Fc Immunomodulator
-
XW0VXL Erdafitinib Antineoplastic
-
XW0VXL Lifileucel Immunotherapy
-
XW0VXM Baricitinib
-
XW0VXM Brexucabtagene Autoleucel Immunotherapy
-
XW0VXM Esketamine Hydrochloride
-
XW0VXN Lisocabtagene Maraleucel Immunotherapy
-
XW0VXN Meropenem-vaborbactam Anti-infective
-
XW0VXP Antibiotic-eluting Bone Void Filler
-
XW0VXQ Tagraxofusp-erzs Antineoplastic
-
XW0VXR Fostamatinib
-
XW0VXR Venetoclax Antineoplastic
-
XW0VXS COVID-19 Vaccine Dose 1
-
XW0VXS Iobenguane I-131 Antineoplastic
-
XW0VXT COVID-19 Vaccine Dose 2
-
XW0VXT Ruxolitinib
-
XW0VXU COVID-19 Vaccine
-
XW0VXU Imipenem-cilastatin-relebactam Anti-infective
-
XW0VXV COVID-19 Vaccine Dose 3
-
XW0VXV Gilteritinib Antineoplastic
-
XW0VXW Caplacizumab
-
XW0VXW COVID-19 Vaccine Booster
-
XW0VXX Broad Consortium Microbiota-based Live Biotherapeutic Suspension
-
XW0VXX Tixagevimab and Cilgavimab Monoclonal Antibody
-
XW0VXY Other New Technology Monoclonal Antibody
-
-